• Maraviroc: CCR5 Biology Beyond HIV Entry

  2026-08-23

  Maraviroc, also known as UK-427857, is more than a tool for HIV-1 entry inhibition. This article examines how CCR5-directed pharmacology can dissect extracellular-vesicle signaling in rheumatoid arthritis while improving assay design across HIV tropism studies and inflammation research.

• OLIG2 Synthetic mRNA Drives Rapid hiPSC-to-OL Differentiatio

  2026-08-22

  Xu and colleagues developed a transgene-free strategy for converting human induced pluripotent stem cells into oligodendrocyte progenitor cells using repeated delivery of modified OLIG2 messenger RNA carrying the S147A mutation. The six-day induction workflow generated NG2-positive progenitors at greater than 70% purity, and the cells subsequently matured into functional oligodendrocytes capable of promoting remyelination in vivo.

• CCG-1423 Workflow for RhoA Signaling Studies

  2026-08-22

  CCG-1423 is a transcriptional-pathway RhoA inhibitor for dissecting MRTF-A nuclear import, proliferation, invasion, and apoptosis. This workflow also shows how to interpret RhoA/ROCK signaling and tight-junction phenotypes without assuming that CCG-1423 directly blocks ROCK1 kinase activity.

• Otilonium Bromide in Cholinergic Assays

  2026-08-21

  Otilonium Bromide provides a practical antimuscarinic perturbation tool for separating acetylcholine-driven effects in smooth muscle and neuronal assays. This guide translates product specifications and a structure-based screening study into workable assay design, controls, and troubleshooting decisions without overstating antiviral relevance.

• Streptavidin-FITC for LNP Trafficking

  2026-08-20

  Streptavidin-FITC turns biotin labeling into a high-affinity fluorescence readout for studying lipid nanoparticle trafficking. This article explains how assay architecture, controls, and endosomal interpretation can reveal delivery failures that simple uptake measurements miss.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-20

  Pair direct Cy5 tracking with EGFP expression to separate cellular uptake from productive translation in gene-delivery experiments. This dual-readout reporter is especially useful for benchmarking electroporation, nanoparticles, and macrophage-oriented delivery workflows without relying on secondary mRNA detection.

• LEE011 Succinate: pH-Aware Assay Design

  2026-08-19

  Discover how LEE011 succinate, a selective CDK inhibitor, can be evaluated through pH-aware dissolution and cell-cycle experiments. This evidence-based guide connects biorelevant solubility behavior with more interpretable cancer research assays.

• G-15: G Protein-Coupled Estrogen Receptor Antagonist

  2026-08-19

  G-15 is a selective G protein-coupled estrogen receptor antagonist for separating GPR30 signaling from classical estrogen receptor activity. This guide translates its calcium, PI3K/Akt, proliferation, and spinal pain-model applications into practical workflows with dose selection, controls, and troubleshooting advice.

• Cyanine 3 Tyramide in Sensitive Tissue Assays

  2026-08-18

  Cyanine 3 Tyramide combines orange-red fluorescence with enzyme-mediated deposition to strengthen weak molecular signals in tissue and cell workflows. Its strongest use cases are low-abundance transcript detection, comparative neuroanatomy, and carefully controlled multiplex assays where conventional labeling may lack sensitivity.

• Hoechst 33342/PI Double Staining Kit for RCC

  2026-08-18

  This dual-fluorescence workflow separates viable, apoptotic, and membrane-compromised RCC cells through chromatin morphology and PI uptake. It is especially useful for testing syringin–sunitinib combinations, comparing treatment time points, and troubleshooting apparent drug-response differences.

• Tobramycin Workflows for Gram-Negative Research

  2026-08-17

  Build reproducible susceptibility, inoculum-effect, and resistance assays with Tobramycin, a water-soluble aminoglycoside antibiotic and bacterial protein synthesis inhibitor. This guide translates a large comparative in vitro study into practical plate design, control selection, and troubleshooting decisions for modern microbiology research.

• PPM-18 Workflows for iNOS and NF-κB Research

  2026-08-17

  PPM-18 provides a practical way to connect NF-κB activation with downstream iNOS expression, nitrite accumulation, and inflammatory cytokine release. This workflow-focused guide shows how to prepare the compound, design macrophage assays, interpret sepsis-relevant endpoints, and troubleshoot common sources of variability.

• Anti Reverse Cap Analog for Synthetic mRNA

  2026-08-16

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, gives in vitro transcription workflows a directionally selective Cap 0 structure designed for stronger protein output. Its value is especially clear when repeated, transient expression is needed for cellular reprogramming, mRNA therapeutics research, or other high-expression assays.

• Targeted SPP1 Inhibition in Tumor-Associated Myeloid Cells

  2026-08-15

  The reference study combines a macrophage phenotypic screen with TAM-avid nanodelivery to suppress SPP1 in tumor-associated myeloid cells. Its lead candidate, CANDI460, reduced SPP1 expression in vitro and in vivo and produced tumor remissions in several murine models, while also illustrating the distinction between biomarker association and therapeutically actionable macrophage state.

• Streptavidin-FITC for Biotin Detection Workflows

  2026-08-14

  Streptavidin-FITC converts biotinylated antibodies, probes, and proteins into a measurable green-fluorescence signal across imaging and flow workflows. This guide applies the reagent to the ST3GAL1–Fusobacterium nucleatum colorectal cancer model while emphasizing assay controls, starting conditions, and troubleshooting decisions.

8462 records 1/565 page Next 12345 下5页 Last page